Trends in GLP‐1 Receptor Agonist Prescribing Without an Apparent FDA‐Approved Indication

Babak J. Orandi, Leila Yan, Macey L. Levan, Holly F. Lofton, Karan R. Chhabra, Christine J. Ren‐Fielding, S. Ali Husain, Mara A. McAdams‐DeMarco, Dorry L. Segev, Michal A. Mankowski, Allan B. Massie
Obesity · Wiley · 2026-10-28 · DOI: 10.1002/oby.70301

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles